11.2 Capital·Dec 30, 2017Data-Driven Health 2Almost a year ago, we published our perspective on the data-driven health landscape. Since then we’ve continued to seek out opportunities…
11.2 Capital·Oct 18, 2017How Artificial Intelligence is Transforming Drug Discovery & DevelopmentAccording to the 2015 Tufts Center for the Study of Drug Development, it now costs $2.6B to get a new drug to market. This figure…A response icon1A response icon1
11.2 Capital·May 29, 2017How Innovative Healthcare Companies Use AI to Put Patients FirstInterview of our Founding and Managing Partner Shelley Zhuang